ProPhase Labs Receives Notice from NASDAQ Regarding Minimum Bid Price Requirement On December 26, 2024, ProPhase Labs, Inc. (NASDAQ: PRPH) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC, indicating that the bid
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read ProPhase Labs’s 8K filing here. About ProPhase Labs (Get Free Report) ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: […]
More Stories
Appeals Court Allows Trump Admin Effort Targeting Noncitizen Voting
By Zachary Stieber A federal appeals court on Nov. 3 reinstated a decision that stays a restraining order that had...
US Manufacturing Expands for 10th Straight Month Amid High Input Costs
By Bill Pan U.S. manufacturing activity strengthened in October as new orders increased, although raw materials became more expensive and...
America Votes: What to Expect
By Lawrence Wilson Democrats appear poised to win control of the House and possibly the Senate on Nov. 3 as...
One Canadian Confirmed Among 69 Victims of Fatal Spanish Train Crash
By Jennifer Cowen Global Affairs has confirmed one Canadian was killed in last week’s high-speed rail collision in Spain. Sixty-nine...
All of Us Are Dead Season 2: Recent Updates and Cast Members
After letting fans wait for almost 4 years, All of Us Are Dead is getting ready for the continuation of...
US Took Enforcement Action Against 2.2 Million Illegal Immigrants, Officials Say
By Jack Phillips U.S. immigration officials say that the second Trump administration has moved to terminate or revoke the status...